Jan 16, 2023 Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Present Data at the 2023 ASCO Gastrointestinal (GI) Cancers Symposium


Rutgers Cancer Institute of New Jersey, a leader in cutting-edge clinical trials and health outcomes analyses and a designated Comprehensive Cancer Center by the National Cancer Institute, together with RWJBarnabas Health, today announced that data from its Gastrointestinal Oncology Program will be presented at the 2023 Gastrointestinal (GI) Cancers Symposium, being held in person in San Francisco and online from January 19 to 21. The GI Cancers Symposium is a global meeting featuring the latest innovative science, solution-focused strategies, and multidisciplinary approaches in GI cancer treatment, research, and care. Read More

Howard S. Hochster, MD, FACP, director of the Rutgers Cancer Institute of New Jersey Gastrointestinal Oncology Program and Associate Director for Clinical Research and director of Oncology Research at RWJBarnabas Health.